Werewolf Therapeutics, Inc. Insider Transactions
Werewolf Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
EVNIN LUKE
Director |
Sell | 60,369 @ $1.29 | $77.88 K | 3,943,359 | 11/03/2025 | 11/03/2025 | |
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 94,063 @ $1.29 | $121.34 K | 6,147,610 | 11/03/2025 | 11/03/2025 | |
|
GADICKE ANSBERT
10 percent owner |
Sell | 94,063 @ $1.29 | $121.34 K | 6,147,610 | 11/03/2025 | 11/03/2025 | |
|
EVNIN LUKE
Director |
Sell | 73,192 @ $1.28 | $93.69 K | 4,003,728 | 10/31/2025 | 11/03/2025 | |
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 114,044 @ $1.28 | $145.98 K | 6,241,673 | 10/31/2025 | 11/03/2025 | |
|
GADICKE ANSBERT
10 percent owner |
Sell | 114,044 @ $1.28 | $145.98 K | 6,241,673 | 10/31/2025 | 11/03/2025 | |
|
EVNIN LUKE
Director |
Sell | 55,795 @ $1.43 | $79.79 K | 4,076,920 | 10/30/2025 | 11/03/2025 | |
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 86,936 @ $1.43 | $124.32 K | 6,355,717 | 10/30/2025 | 11/03/2025 | |
|
GADICKE ANSBERT
10 percent owner |
Sell | 86,936 @ $1.43 | $124.32 K | 6,355,717 | 10/30/2025 | 11/03/2025 | |
|
EVNIN LUKE
Director |
Sell | 86,154 @ $1.55 | $133.54 K | 4,132,715 | 10/29/2025 | 10/29/2025 | |
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 134,240 @ $1.55 | $208.07 K | 6,442,653 | 10/29/2025 | 10/29/2025 | |
|
GADICKE ANSBERT
10 percent owner |
Sell | 134,240 @ $1.55 | $208.07 K | 6,442,653 | 10/29/2025 | 10/29/2025 | |
|
EVNIN LUKE
Director |
Sell | 44,327 @ $1.64 | $72.70 K | 4,218,869 | 10/28/2025 | 10/29/2025 | |
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 69,068 @ $1.64 | $113.27 K | 6,576,893 | 10/28/2025 | 10/29/2025 | |
|
GADICKE ANSBERT
10 percent owner |
Sell | 69,068 @ $1.64 | $113.27 K | 6,576,893 | 10/28/2025 | 10/29/2025 | |
|
MPM BioVentures 2014, L.P.
10 percent owner |
Sell | 72,709 @ $1.72 | $125.06 K | 6,645,961 | 10/27/2025 | 10/29/2025 | |
|
GADICKE ANSBERT
10 percent owner |
Sell | 72,709 @ $1.72 | $125.06 K | 6,645,961 | 10/27/2025 | 10/29/2025 | |
|
EVNIN LUKE
Director |
Sell | 46,664 @ $1.72 | $80.26 K | 4,263,196 | 10/27/2025 | 10/29/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director, 10 percent owner: |
Buy | 162,539 @ $0.98 | $159.29 K | 6,237,482 | 05/14/2025 | 05/14/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director, 10 percent owner: |
Buy | 52,974 @ $0.98 | $51.92 K | 6,074,943 | 05/13/2025 | 05/14/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Werewolf Therapeutics, Inc. FAQ's
The list of insiders at Werewolf Therapeutics, Inc. includes MPM BioVentures 2014, L.P., EVNIN LUKE, GADICKE ANSBERT, RA CAPITAL MANAGEMENT, L.P..
Insiders have sold a total of 5.64 M Werewolf Therapeutics, Inc. shares in the last 12 months for a total of 6.30 M sold.
The following insiders have sold Werewolf Therapeutics, Inc. shares in the last 12 months: MPM BioVentures 2014, L.P. ($2.23 M), EVNIN LUKE ($1.85 M), GADICKE ANSBERT ($2.23 M),
Insiders have purchased a total of 536.43 K Werewolf Therapeutics, Inc. shares in the last 12 months for a total of 487.19 K.
The following insiders have purchased Werewolf Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($487.19 K),